Terms: = Pancreatic cancer AND BRCA1, BRCAI, 672, ENSG00000012048, IRIS, BRCC1, RNF53, PSCP
592 results:
1. Activated NAD+ biosynthesis pathway induces olaparib resistance in brca1 knockout pancreatic cancer cells.
Sasaki Y; Inouchi T; Nakatsuka R; Inoue A; Masutani M; Nozaki T
PLoS One; 2024; 19(4):e0302130. PubMed ID: 38625917
[TBL] [Abstract] [Full Text] [Related]
2. Diagnostic performance of PIVKA-II in identifying recurrent hepatocellular carcinoma following curative resection: a retrospective cohort study.
Zhu W; Wang W; Zheng W; Chen X; Wang X; Xie J; Jiang S; Chen H; Zhu S; Xue P; Jiang X; Li H; Wang G
Sci Rep; 2024 Apr; 14(1):8416. PubMed ID: 38600210
[TBL] [Abstract] [Full Text] [Related]
3. Olaparib not cost-effective as maintenance therapy for platinum-sensitive, brca1/2 germline-mutated metastatic pancreatic cancer.
Mehra T; Lupatsch JE; Kössler T; Dedes K; Siebenhüner AR; von Moos R; Wicki A; Schwenkglenks ME
PLoS One; 2024; 19(4):e0301271. PubMed ID: 38573891
[TBL] [Abstract] [Full Text] [Related]
4. Population-based BRCA germline mutation screening in the Han Chinese identifies individuals at risk of BRCA mutation-related cancer: experience from a clinical diagnostic center from greater Shanghai area.
Wu Z; Zhang Q; Jin Y; Zhang X; Chen Y; Yang C; Tang X; Jiang H; Wang X; Zhou X; Yu F; Wang B; Guan M
BMC Cancer; 2024 Apr; 24(1):411. PubMed ID: 38566028
[TBL] [Abstract] [Full Text] [Related]
5. Frizzled class receptor 5 contributes to ovarian cancer chemoresistance through aldehyde dehydrogenase 1A1.
Xia Y; Wang S; Sun Y; Wang W; Chang S; Zhang Z; Zhao C
Cell Commun Signal; 2024 Mar; 22(1):194. PubMed ID: 38539211
[TBL] [Abstract] [Full Text] [Related]
6. pancreatic cancer biomarkers: A pathway to advance in personalized treatment selection.
Brozos-Vázquez E; Toledano-Fonseca M; Costa-Fraga N; García-Ortiz MV; Díaz-Lagares Á; Rodríguez-Ariza A; Aranda E; López-López R
Cancer Treat Rev; 2024 Apr; 125():102719. PubMed ID: 38490088
[TBL] [Abstract] [Full Text] [Related]
7. Abrogation of KLF5 sensitizes
Zhang Z; Liu Y; Xu Y; Xu Z; Jia J; Jin Y; Wang W; Liu L
Acta Biochim Biophys Sin (Shanghai); 2024 Apr; 56(4):576-585. PubMed ID: 38433576
[TBL] [Abstract] [Full Text] [Related]
8. A Somatic BRCA2-Mutated pancreatic Adenocarcinoma With Sustained Exceptional Response to Modified FOLFIRINOX.
Jamison JK; May MS; Raufi AG; Luk L; Wong W; Mundi PS; Manji GA
Oncologist; 2024 Apr; 29(4):350-355. PubMed ID: 38394390
[TBL] [Abstract] [Full Text] [Related]
9. Germline mutations of homologous recombination genes and clinical outcomes in pancreatic cancer: a multicenter study in Taiwan.
Cheng SM; Su YY; Chiang NJ; Wang CJ; Chao YJ; Huang CJ; Tsai HJ; Chen SH; Chang CY; Tsai CR; Li YJ; Yen CJ; Chuang SC; Chang JS; Shan YS; Hwang DY; Chen LT
J Biomed Sci; 2024 Feb; 31(1):21. PubMed ID: 38350919
[TBL] [Abstract] [Full Text] [Related]
10. Targeting BRCA and PALB2 in pancreatic cancer.
Anbil S; Reiss KA
Curr Treat Options Oncol; 2024 Mar; 25(3):346-363. PubMed ID: 38311708
[TBL] [Abstract] [Full Text] [Related]
11. A novel targeted NGS panel identifies numerous homologous recombination deficiency (HRD)-associated gene mutations in addition to known BRCA mutations.
Vogel A; Haupts A; Kloth M; Roth W; Hartmann N
Diagn Pathol; 2024 Jan; 19(1):9. PubMed ID: 38184614
[TBL] [Abstract] [Full Text] [Related]
12. Beyond BRCA: Diagnosis and management of homologous recombination repair deficient pancreatic cancer.
LaRose M; Manji GA; Bates SE
Semin Oncol; 2024; 51(1-2):36-44. PubMed ID: 38171988
[TBL] [Abstract] [Full Text] [Related]
13. Comprehensive review of pancreatic acinar cell carcinoma: epidemiology, diagnosis, molecular features and treatment.
Ikezawa K; Urabe M; Kai Y; Takada R; Akita H; Nagata S; Ohkawa K
Jpn J Clin Oncol; 2024 Mar; 54(3):271-281. PubMed ID: 38109477
[TBL] [Abstract] [Full Text] [Related]
14. SAKK57/16 Nab-paclitaxel and Gemcitabine in Soft Tissue Sarcoma (NAPAGE): a phase I/II trial.
Digklia A; Kollár A; Dietrich D; Kronig MN; Britschgi C; Rordorf T; Joerger M; Krasniqi F; Metaxas Y; Colombo I; Ribi K; Rothermundt C
Eur J Cancer; 2024 Jan; 197():113470. PubMed ID: 38096656
[TBL] [Abstract] [Full Text] [Related]
15. Cost-Effectiveness Analysis of Screening for pancreatic cancer Among High-Risk Populations.
Peters MLB; Eckel A; Seguin CL; Davidi B; Howard DH; Knudsen AB; Pandharipande PV
JCO Oncol Pract; 2024 Feb; 20(2):278-290. PubMed ID: 38086003
[TBL] [Abstract] [Full Text] [Related]
16. Association of pancreatic Adenocarcinoma Location With DNA Damage Response Status and Response to Platinum-Based Therapy.
Micaily I; Blais EM; Carhart R; Lam S; Cohen SJ; Cannaday SJ; Halverson D; Matrisian LM; DeArbeloa P; Thach D; Petricoin E; Pishvaian MJ; Lavu H; Yeo CJ; Mallick AB
JCO Precis Oncol; 2023 Sep; 7():e2200648. PubMed ID: 38085059
[TBL] [Abstract] [Full Text] [Related]
17. Aneuploidy Landscape in Precursors of Ovarian cancer.
Wang Y; Douville C; Chien YW; Wang BG; Chen CL; Pinto A; Smith SA; Drapkin R; Chui MH; Numan T; Vang R; Papadopoulos N; Wang TL; Shih IM
Clin Cancer Res; 2024 Feb; 30(3):600-615. PubMed ID: 38048050
[TBL] [Abstract] [Full Text] [Related]
18. brca1/2 reversion mutations in a pan-cancer cohort.
Nakamura K; Hayashi H; Kawano R; Ishikawa M; Aimono E; Mizuno T; Kuroda H; Kojima Y; Niikura N; Kawanishi A; Takeshita K; Suzuki S; Ueno S; Okuwaki K; Sasaki J; Yamaguchi M; Masuda K; Chiyoda T; Yamagami W; Okada C; Nohara S; Tanishima S; Nishihara H
Cancer Sci; 2024 Feb; 115(2):635-647. PubMed ID: 38041241
[TBL] [Abstract] [Full Text] [Related]
19. DAXX promotes centromeric stability independently of ATRX by preventing the accumulation of R-loop-induced DNA double-stranded breaks.
Pinto LM; Pailas A; Bondarchenko M; Sharma AB; Neumann K; Rizzo AJ; Jeanty C; Nicot N; Racca C; Graham MK; Naughton C; Liu Y; Chen CL; Meakin PJ; Gilbert N; Britton S; Meeker AK; Heaphy CM; Larminat F; Van Dyck E
Nucleic Acids Res; 2024 Feb; 52(3):1136-1155. PubMed ID: 38038252
[TBL] [Abstract] [Full Text] [Related]
20. PARP Inhibitor Sensitizes
Kim C; Kim D; Lee DS; Lee S; Yoo C; Kim KP
Anticancer Res; 2023 Dec; 43(12):5523-5534. PubMed ID: 38030179
[TBL] [Abstract] [Full Text] [Related]
[Next]
